Home/Filings/4/0001140361-18-028646
4//SEC Filing

Naider Avi Z. 4

Accession 0001140361-18-028646

CIK 0001581720other

Filed

Jun 13, 8:00 PM ET

Accepted

Jun 14, 5:10 PM ET

Size

5.4 KB

Accession

0001140361-18-028646

Insider Transaction Report

Form 4
Period: 2018-06-13
Transactions
  • Award

    Director Stock Option (right to buy)

    2018-06-13+8,7508,750 total
    Exercise: $180.98Exp: 2028-06-12Common Stock (8,750 underlying)
Footnotes (1)
  • [F1]The stock option vests and becomes exercisable in 12 equal monthly installments beginning one month after the grant date, until such time as the option is 100% vested, subject to the continuing service of the Reporting Person on each vesting date.

Documents

1 file

Issuer

Loxo Oncology, Inc.

CIK 0001581720

Entity typeother

Related Parties

1
  • filerCIK 0001612217

Filing Metadata

Form type
4
Filed
Jun 13, 8:00 PM ET
Accepted
Jun 14, 5:10 PM ET
Size
5.4 KB